Effects of carbohydrates of differing molecular-size on diarrhoea-predominant irritable bowel syndrome (IBS-D)
Phase 4
Recruiting
- Conditions
- Irritable bowel syndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- Registration Number
- ACTRN12613000501741
- Lead Sponsor
- Department of Gastroenterology, Central Clinical School, Monash University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Patients with diarrhoea-predominant irritable bowel syndrome with reported good symptom control while following a low FODMAP diet
Exclusion Criteria
1.Organic disease or condition predisposing the patient to diarrhoea (e.g. coeliac disease, inflammatory bowel disease, bowel resection)
2.Use of antidiarrhoeal medications for one week prior to study commencement
3.Probiotic or prebiotic use for two weeks prior to study commencement
4.Antibiotic use for two weeks prior to study commencement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method